|
Getting your Trinity Audio player ready...
|
The Viral Threat Hiding in Plain Sight: Between August 2024 and July 2025, the CDC’s NoroSTAT system recorded 2,675 norovirus outbreaks across the United States. A genetic shift has emerged: the GII.17 strain has overtaken the long-dominant GII.4 lineage, now responsible for roughly 75 percent of reported cases. Health officials warn this strain replacement increases outbreak frequency and severity, as current cleaning and immunity defenses are quickly becoming outdated.
Why It Matters
Norovirus remains one of the most contagious and costly viral threats, spreading rapidly in schools, nursing homes, cruise ships, and hospitals. Just a few viral particles can infect hundreds, causing closures, staffing shortages, and economic losses that ripple through communities. Traditional disinfectants often fail to reach hidden areas or destroy new viral variants, allowing persistent contamination in high-contact environments.
The TOMI Advantage
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) delivers a validated defense with its SteraMist® ionized Hydrogen Peroxide (iHP®) technology—proven to kill 99.9999 percent (six-log reduction) of viruses, bacteria, and spores in seconds. The gas-like mist penetrates surfaces, air spaces, and complex equipment without leaving corrosive residues, making it ideal for classrooms, healthcare facilities, transportation systems, and hospitality settings requiring rapid re-entry and safe, residue-free disinfection.
Investor Angle
Norovirus is both a public-health threat and an economic disruptor. Each outbreak drives costly shutdowns and reputational risk. TOMI’s SteraMist® platform—trusted by hospitals, government agencies, and Fortune 500 companies—offers a scalable, automation-ready clean-tech solution for evolving viral challenges.
Adding to investor focus, TOMI Environmental (NASDAQ: TOMZ) is scheduled to release its Q3 2025 earnings on Friday, November 14, 2025, providing fresh insight into revenue growth, recurring-sales progress, and expanding global demand for its SteraMist® technology.
With infection control, food safety, and CleanTech innovation converging, TOMI stands at the forefront of a market where science, scalability, and public-health urgency are rewriting the standards for global disinfection.